Inhibition of oxytocic and hypotensive activities of bradykinin by bradykinin-binding antibodies.
D000804:Angiotensin II / Q000494:pharmacology; D000818:Animals; D000906:Antibodies / Q000032:analysis; D000918:Antibody Specificity; D001794:Blood Pressure / Q000187:drug effects*; D001920:Bradykinin / Q000037:antagonists & inhibitors* / Q000276:immunology / Q000302:isolation & purification; D002250:Carbon Radioisotopes; D003956:Dialysis; D004054:Diethylstilbestrol / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D005260:Female; D007114:Immunization; D066298:In Vitro Techniques; D007457:Iodine Radioisotopes; D009119:Muscle Contraction / Q000187:drug effects; D010047:Ovalbumin; D010120:Oxytocics / Q000037:antagonists & inhibitors*; D010121:Oxytocin / Q000494:pharmacology; D011817:Rabbits / Q000276:immunology; D051381:Rats; D014599:Uterus / Q000187:drug effects; D014667:Vasopressins / Q000494:pharmacology
D000906:Antibodies; D002250:Carbon Radioisotopes; D007457:Iodine Radioisotopes; D010120:Oxytocics; D014667:Vasopressins; D000804:Angiotensin II; D010121:Oxytocin; D004054:Diethylstilbestrol; D010047:Ovalbumin; D001920:Bradykinin